For decades, the field of human genomics has faced a significant "representation crisis." Because the vast majority of large-scale genetic studies have focused on populations of European descent, there has been a persistent fear that the resulting insights—and the precision medicine tools built from them—would fail to work for the rest of the world.
However, a growing body of evidence suggests that the fundamental biological "engine" of human disease is remarkably consistent across the globe. While the specific genetic markers used to track risk may vary between populations, the underlying pathways and mechanisms are often universal.
The Universality of Biological Drivers
The intuition behind this research direction is that core physiological processes—such as how the brain develops, how the body senses minerals, or how the immune system responds to threats—are evolutionary "hard-wired" traits. Because these systems were established long before the major human migrations, the genetic variants that disrupt them often exert similar effects regardless of a person’s ancestral background.
For example, Karen Kapur and colleagues demonstrated that variations in the CASR gene, which regulates serum calcium, are the primary genetic drivers of calcium levels in both European and Indian Asian populations Genome-Wide Meta-Analysis for Serum Calcium Identifies Significantly Associated SNPs near the Calcium-Sensing Receptor (CASR) Gene. Similarly, Luis M. García-Marín found that the genetic architecture governing subcortical brain volumes is largely conserved across diverse global ancestries Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries.
This conservation extends even to complex chronic conditions. Yiyi Ma showed that the clinical progression and biomarkers for polycystic kidney disease are nearly identical between Chinese and Western cohorts Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease. When the biological mechanism is fundamental, the population-specific "noise" of genetic history becomes secondary to the shared "signal" of disease.
Conserved Pathways Across the Omics Stack
The robustness of these mechanisms isn't just visible in DNA; it persists through the "layers" of biology, from gene expression (transcriptomics) to proteins (proteomics) and metabolites.
- Epigenetics: Mithun Das identified DNA methylation signatures at the CPT1A locus that correlate with metabolic syndrome in both European and African ancestry groups Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study.
- Metabolomics: Tara Eicher and her team discovered that certain gene-metabolite relationships in pediatric asthma remain consistent regardless of age, ethnicity, or geography Consistent Multi-Omic Relationships Uncover Molecular Basis of Pediatric Asthma IgE Regulation.
- Proteomics: Recent work in Diabetologia (2024) identified a core set of proteins associated with Type 2 Diabetes risk that are shared across diverse racial and ethnic groups.
These findings suggest that while different populations might arrive at a disease state through slightly different genetic "routes," the molecular "destination"—the actual dysfunction in proteins or metabolism—is often the same.
Disentangling Ancestry from Disease
If the underlying biology is so similar, why do Polygenic Risk Scores (PRS) often lose predictive power when moved from one population to another? The problem is often not the biology itself, but the statistical "confounding" of ancestry.
Genetic markers (SNPs) are often just "tags" for the actual causal variant. Because different populations have different patterns of genetic inheritance (linkage disequilibrium), a tag that works in Europeans might not be close to the causal variant in Africans. Prashnna Gyawali and Zihuai He addressed this by developing DisPred, a deep-learning framework that "disentangles" ancestry representations from disease signals Improving genetic risk prediction across diverse population by disentangling ancestry representations. By stripping away the population-specific noise, they reveal the universal genetic drivers that maintain predictive power across groups.
This approach helps overcome the limitations noted by researchers like Honglei Chen, who found that standard insomnia risk scores lose power across racial groups Polygenic Risk for Insomnia in Adolescents of Diverse Ancestry. The failure isn't in the shared biology of sleep, but in our ability to isolate it from ancestral background.
The Power of Global Meta-Analysis
The ultimate proof of this conservation comes from massive, global collaborations. The Global Biobank Meta-analysis Initiative (GBMI), led by researchers like Wei Zhou and Masahiro Kanai, analyzed 2.1 million individuals across 14 diseases Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases. They found that a staggering 96% of identified genetic effects were stable across diverse healthcare systems and ancestries.
This stability allows researchers to use "discovery-and-replication" frameworks across populations. Janna Saarela demonstrated this by validating the PRKCA gene's role in Multiple Sclerosis across both isolated Finnish and heterogeneous Canadian populations PRKCA and Multiple Sclerosis: Association in Two Independent Populations. When a finding holds up in such different genetic contexts, it confirms that the association is a robust biological driver rather than a population-specific artifact.
By shifting the focus from what makes populations different to the biological mechanisms they share, this research direction is proving that the future of precision medicine can be both globally inclusive and biologically precise.